The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(1-(5-(4-fluoro-1H-pyrazol-1-yl)pyrazin-2-yl)ethyl)-9-(4-methyl-6-(5-methyl-1H-pyrazol-3-ylamino)pyrimidin-2-yl)-2,9-diazaspiro[5.5]undecan-1-one ID: ALA4870957
PubChem CID: 164622935
Max Phase: Preclinical
Molecular Formula: C27H32FN11O
Molecular Weight: 545.63
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(Nc2cc(C)[nH]n2)nc(N2CCC3(CCCN([C@@H](C)c4cnc(-n5cc(F)cn5)cn4)C3=O)CC2)n1
Standard InChI: InChI=1S/C27H32FN11O/c1-17-11-22(33-23-12-18(2)35-36-23)34-26(32-17)37-9-6-27(7-10-37)5-4-8-38(25(27)40)19(3)21-14-30-24(15-29-21)39-16-20(28)13-31-39/h11-16,19H,4-10H2,1-3H3,(H2,32,33,34,35,36)/t19-/m0/s1
Standard InChI Key: QSTYMDLOACKCHV-IBGZPJMESA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
20.3740 -25.2000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1741 -25.3664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4301 -26.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7182 -24.7567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5165 -24.9243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0604 -24.3153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8046 -23.5383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9998 -23.3737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4595 -23.9839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3455 -22.9254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1587 -23.0061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4868 -22.2576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8763 -21.7143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1710 -22.1270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.2851 -22.0831 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.1545 -24.4868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7417 -25.1926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1443 -25.8990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9613 -25.9058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9698 -24.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9493 -22.3696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3538 -23.0753 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3612 -21.6669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9574 -20.9616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1431 -20.9586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7343 -21.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1404 -22.3691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3686 -20.2554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9171 -21.6670 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5087 -22.3748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6992 -22.4614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5295 -23.2608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2374 -23.6691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8444 -23.1221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7831 -23.5934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9427 -23.7783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3437 -24.4820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5686 -23.7858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1659 -23.0760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3813 -23.7815 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 6
2 3 1 0
2 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 10 1 0
7 10 1 0
12 15 1 0
16 17 1 0
16 20 1 0
17 18 1 0
18 19 1 0
19 1 1 0
1 20 1 0
22 21 1 0
21 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 21 1 0
24 28 1 0
26 29 1 0
29 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 1 0
34 30 2 0
32 35 1 0
22 36 1 0
22 39 1 0
36 37 1 0
37 16 1 0
16 38 1 0
38 39 1 0
20 40 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 545.63Molecular Weight (Monoisotopic): 545.2775AlogP: 3.65#Rotatable Bonds: 6Polar Surface Area: 133.64Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.27CX Basic pKa: 7.59CX LogP: 3.10CX LogD: 3.04Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.37Np Likeness Score: -1.37
References 1. Luo Z, Wang L, Fu Z, Shuai B, Luo M, Hu G, Chen J, Sun J, Wang J, Li J, Chen S, Zhang Y.. (2021) Discovery and optimization of selective RET inhibitors via scaffold hopping., 47 [PMID:34058344 ] [10.1016/j.bmcl.2021.128149 ]